GlassScriptPhysician profile
Sandra Salas
NPI 1770153454
$1,374.78
in general payments reported to CMS, 2019-2025
24 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.81 · 2022: $194 · 2023: $288 · 2024: $360 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,105.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $308.01 | 2023-2025 | Gemtesa |
| Axonics, INC. | $129.75 | 2024 | Axonics |
| Urovant Sciences INC | $126.28 | 2021-2022 | |
| Janssen Biotech, INC. | $110.09 | 2025 | Erleada |
| Boston Scientific Corporation | $109.77 | 2024-2025 | Ams 700, Moses |
| 180 Medical, INC. | $79.88 | 2023-2025 | Gentlecath |
| Convatec INC. | $76.80 | 2022 | |
| Astellas Pharma US INC | $62.83 | 2023 | Myrbetriq |
| Tolmar, INC. | $43.10 | 2023 | |
| Procept Biorobotics Corporation | $41.03 | 2024-2025 | Aquabeam System |
| Blue Earth Diagnostics | $27.00 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $26.46 | 2023 | Seglentis |
| Myriad Genetic Laboratories, INC. | $22.98 | 2022 | |
| Endo USA, INC. | $22.50 | 2025 | Xiaflex |
| Edap Technomed INC | $22.08 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $21.95 | 2024 | Xt Cdx |
| Progenics Pharmaceuticals, INC. | $20.85 | 2025 | |
| Mission Pharmacal Company | $20.29 | 2024 | Uribel Tabs |
| Antares Pharma, INC. | $18.33 | 2025 | Xyosted |
| Urogen Pharma, INC. | $17.73 | 2025 | |
| Immunitybio, INC. | $17.53 | 2025 | |
| Olympus America INC. | $16.99 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.51 | 2025 | |
| Clarus Therapeutics INC. | $16.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Salas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.